# Valiant Laboratories Ltd (VALIANTLAB)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹75.97
Day Change: -0.74%
52W High: ₹124.4
52W Low: ₹49.51
Market Cap: ₹408 Cr

## Valuation
P/E: 0
P/B: 1.18
EPS: ₹-0.83
Book Value: ₹63.44
Dividend Yield: 0%

## Returns
1Y Return: -8.13%

## Profitability
ROE: -1.2%
ROCE: -1.68%
Debt/Equity: 0.15
Revenue Growth: 59.5%
Profit Growth: 104.2%
EBITDA Margin: 3.63%
Operating Margin: 2.23%

## About
Valiant Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Valiant Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Press Release / Media Release

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:59:25.214Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:25.214Z
Quant Updated: 2026-05-18T22:59:25.214Z
Sentiment Updated: 2026-05-18T22:59:25.214Z
Financials Status: current
Financials Updated: 2026-05-19T13:31:27.798Z
Financials Last Attempt: 2026-05-19T13:31:27.798Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹133.38 Cr
Operating Profit: ₹-3.52 Cr (OPM -2.64%)
Net Profit: ₹-2.2 Cr
Tax: ₹0.69 Cr

## Annual P&L History
FY25: Rev ₹133.38Cr | PAT ₹-2.2Cr | OPM -2.64%
FY24: Rev ₹182.06Cr | PAT ₹0.32Cr | OPM -5.7%
FY23: Rev ₹333.91Cr | PAT ₹29Cr | OPM 10.06%

## Balance Sheet (FY25)
Total Assets: ₹400.86 Cr
Total Liabilities: ₹166.55 Cr
Borrowings: ₹121.69 Cr
Cash: ₹4.92 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Santosh Shantilal Vora, MD & Executive Director
- Paresh Shashikant Shah, Whole-Time Director & CFO
- Kiran  Mudaliar, Assistant Manager of Accounts
- Akshay Dnyaneshwar Gangurde C.S., Company Secretary & Compliance Officer
- Nilesh Vinayak Patil, Analytical Head

---
Source: rupiya.io/stocks/valiantlab
Disclaimer: For research and education only. Not investment advice.